Celator Pharmaceuticals, Inc.
(NASDAQ : CPXX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.49%35.820.8%$770.72m
JNJJohnson & Johnson
-0.08%124.140.6%$763.61m
ABBVAbbVie, Inc.
0.83%106.862.1%$726.91m
MRKMerck & Co., Inc.
-1.01%58.550.6%$604.37m
BMYBristol-Myers Squibb Company
-0.12%52.651.4%$504.55m
LLYEli Lilly and Company
0.02%82.091.0%$360.93m
AZNAstraZeneca PLC Sponsored ADR
1.17%36.761.3%$155.24m
NVSNovartis AG Sponsored ADR
-0.01%77.050.2%$134.94m
GSKGlaxoSmithKline plc Sponsored ADR
0.19%40.110.2%$111.46m
NVONovo Nordisk A/S Sponsored ADR Class B
0.33%48.880.1%$80.62m
SNYSanofi Sponsored ADR
-0.04%38.870.2%$45.16m
LCILannett Company, Inc.
4.80%16.9337.9%$12.87m
EPIXESSA Pharma Inc
-5.07%3.370.0%$0.19m
AKTXAkari Therapeutics Plc Sponsored ADR
-7.36%1.761.7%$0.11m

Company Profile

Celator Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of biopharmaceutical products. It intends to provide chemotherapies and molecularly targeted agents to deliver anti-cancer activity and enhance treatment outcomes for cancer patients. It operates under the CombiPlex platform. Its products include VYXEOS, CPX-1, and CPX-8. The company was founded by Lawrence David Mayer and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ.